Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Alzheimer’s Disease Drugs Aduhelm, Leqembi May Cause Brain Shrinkage: Study Aduhelm and Leqembi side effects may actually speed up brain atrophy, making Alzheimer’s disease and dementia problems worse, researchers warn. April 19, 2023 Martha Garcia Add Your Comments A controversial new type of Alzheimer’s drug could actually speed up the progression of dementia in some cases by causing brain shrinkage, according to the findings of a new study. Australian researchers warn that the drugs, Aduhelm and Leqembi, which belong to a subclass of anti-amyloid beta drugs, may cause accelerated dementia in mildly cognitively impaired individuals. Their findings were published last month in the medical journal Neurology. Aduhelm (aducanumab) became the first novel therapy introduced for the treatment of Alzheimer’s since 2003, after it was granted approval through the FDA’s Accelerated Approval Program in June 2022. The drug is designed to reduce the presence of amyloid beta plaques in the brain, which are believed to be linked to the progression of the disease. However, the decision to approve Aduhelm immediately raised questions, since it was allowed on the market in the U.S. over the recommendations of an independent FDA advisory panel, which unanimously indicated the drug should not be approved due to questions about Aduhelm’s effectiveness treating Alzheimer’s. Leqembi (lecanemab), a similar drug, was just approved in January 2023. Potential Side Effects of Aduhelm and Leqembi The findings of this new study raise new signals about the potential side effects of Aduhelm and Leqembi, which are especially concerning given existing questions about the lack of benefits provided by the medications. Researchers from the University of Melbourne, Australia conducted a meta-analysis of clinical trials on this new class of dementia drugs. The report examined 31 clinical trials, looking for changes in the volume of the brain and investigating any Amyloid-Related Imaging Abnormalities (ARIA) detected during those trials. Two types of anti-amyloid beta drugs were compared; secretase inhibitors and ARIA-inducing monoclonal antibodies. Researchers found patients given the highest doses of these drugs appeared to experience accelerated volume changes to the whole brain, as well as the ventrical and hippocampus portions. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Anti-amyloid drugs are used to reduce amyloid plaques, which some research has linked with Alzheimer’s disease. But reducing amyloid plaque has not been proven to improve the disease, and many anti-amyloid drugs failed to improve the condition in clinical trials. According to the findings, secretase inhibitors accelerated brain atrophy to the hippocampus by 20% and to the entire brain by 22%. However, ARIA-inducing monoclonal antibodies, which include both Aduhelm and Leqembi, led to roughly 28% more brain shrinkage compared to control groups. Patients using those drugs also experienced a 39% increase in ventricular enlargement or the empty spaces of the brain. Researchers said the monoclonal drugs led to a level of brain shrinkage, and potential dementia progression, eight months earlier than if they didn’t receive treatment at all. However, they noted the shrinkage was not conclusively linked to the reduction of amyloid plaques. Critics propose the shrinkage may be linked to a reduction of inflammation in the brain and the clearing of antibodies. That theory is not proven, and brain shrinkage can be an indicator of neurodegeneration and brain damage. “These findings reveal the potential for anti-amyloid therapies to compromise long-term brain health by accelerating brain atrophy and provide new insight into the adverse impact of ARIA,” wrote study authors. Aduhelm Approval Controversy Scrutiny already surrounds Aduhelm after the FDA’s controversial approval of the drug, which came despite evidence from a clinical trial indicating the drug may not be able to slow Alzheimer’s disease. Aduhelm also failed two of the phase-3 clinical trials, which were ended early because the researchers failed to see improvements among patients. The FDA bucked the unanimous recommendation of its scientific advisory committee and approved the drug for use. Two members of the advisory committee resigned in protest and called the FDA’s move the “worst drug approval decision in recent U.S. history.” Later, after a congressional committee concluded the FDA approved the drug inappropriately and ignored agency protocol, the agency moved to approve the second Alzheimer’s drug, Leqembi. Written by: Martha Garcia Health & Medical Research Writer Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. Tags: Aduhelm, Alzheimer's Disease, Brain Injury, Cognition, Dementia, Leqembi Image Credit: | More Lawsuit Stories Amazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns August 29, 2025 MDL Sought for GLP-1 NAION Lawsuits Against Ozempic, Wegovy, Mounjaro Manufacturers August 29, 2025 Hyperbaric Oxygen Chamber Fires, Injuries Lead to New FDA Safety Recommendations August 29, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Amazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (Posted: 2 days ago) A lawsuit filed over an Amazon fire pit explosion claims a Canadian woman suffered second and third-degree burns due to the device’s dangerous design. MORE ABOUT: TABLETOP FIRE PIT LAWSUITTabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025)Alcohol Fire Pit Recall Lawsuits Are Being Filed Over Severe Burn Injuries and Fatalities (08/07/2025) DraftKings Micro-Betting Causes Addiction Risks in Vulnerable Users, Critics Warn (Posted: 3 days ago) Lawsuits over gambling addictions are being brought against DraftKings, as regulators and health experts warn the platform’s push into micro-betting could heighten risks for vulnerable users. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITDraftKings Class Action Lawsuit Over $1,000 Bonus Bet Promo Dismissed by Federal Judge (08/01/2025)DraftKings ‘Risk-Free’ Bets, Other Promotions Instilled Gambling Addiction: Lawsuit (07/18/2025)FanDuel Class Action Lawsuit Alleges Fantasy Games Constitute Illegal Sports Gambling (07/08/2025) Talcum Powder Ovarian Cancer Settlement Negotiations Set To Kick Off Sept. 4 (Posted: 4 days ago) A federal judge has ordered parties involved in talcum powder ovarian cancer lawsuits to meet on September 4 to begin settlement negotiations. MORE ABOUT: TALCUM POWDER CANCER LAWSUITSWomen Will Have Voice in Any Settlement for Talcum Powder Lawsuits: Court (08/07/2025)Baby Powder Mesothelioma Lawsuit Ends in $42.6M Verdict for Massachusetts Family (08/01/2025)Talcum Powder Injury Lawyers Appointed To Negotiate Settlements With J&J (07/30/2025)
Amazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (Posted: 2 days ago) A lawsuit filed over an Amazon fire pit explosion claims a Canadian woman suffered second and third-degree burns due to the device’s dangerous design. MORE ABOUT: TABLETOP FIRE PIT LAWSUITTabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025)Alcohol Fire Pit Recall Lawsuits Are Being Filed Over Severe Burn Injuries and Fatalities (08/07/2025)
DraftKings Micro-Betting Causes Addiction Risks in Vulnerable Users, Critics Warn (Posted: 3 days ago) Lawsuits over gambling addictions are being brought against DraftKings, as regulators and health experts warn the platform’s push into micro-betting could heighten risks for vulnerable users. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITDraftKings Class Action Lawsuit Over $1,000 Bonus Bet Promo Dismissed by Federal Judge (08/01/2025)DraftKings ‘Risk-Free’ Bets, Other Promotions Instilled Gambling Addiction: Lawsuit (07/18/2025)FanDuel Class Action Lawsuit Alleges Fantasy Games Constitute Illegal Sports Gambling (07/08/2025)
Talcum Powder Ovarian Cancer Settlement Negotiations Set To Kick Off Sept. 4 (Posted: 4 days ago) A federal judge has ordered parties involved in talcum powder ovarian cancer lawsuits to meet on September 4 to begin settlement negotiations. MORE ABOUT: TALCUM POWDER CANCER LAWSUITSWomen Will Have Voice in Any Settlement for Talcum Powder Lawsuits: Court (08/07/2025)Baby Powder Mesothelioma Lawsuit Ends in $42.6M Verdict for Massachusetts Family (08/01/2025)Talcum Powder Injury Lawyers Appointed To Negotiate Settlements With J&J (07/30/2025)